Sulagna Banerjee Selected Research

Diterpenes

1/2019	Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.
5/2017	Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.
1/2017	Modulation of post-translational modifications in β-catenin and LRP6 inhibits Wnt signaling pathway in pancreatic cancer.
1/2017	Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
5/2015	Primary and liver metastasis-derived cell lines from KrasG12D; Trp53R172H; Pdx-1 Cre animals undergo apoptosis in response to triptolide.
8/2014	Sorafenib and triptolide as combination therapy for hepatocellular carcinoma.
6/2014	Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway.
6/2014	Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells.
9/2013	miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death.
10/2012	A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sulagna Banerjee Research Topics

Disease

41	Neoplasms (Cancer) 01/2022 - 01/2012
39	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2012
8	Neoplasm Metastasis (Metastasis) 10/2020 - 07/2013
6	Adenocarcinoma 12/2020 - 07/2013
4	Hypoxia (Hypoxemia) 01/2021 - 01/2017
4	Tics (Tic) 11/2019 - 05/2014
3	Pancreatic Diseases (Pancreatic Disease) 01/2020 - 07/2017
3	Pancreatitis 01/2018 - 10/2016
3	Tuberculosis (Tuberculoses) 05/2015 - 09/2011
2	Dysbiosis 10/2020 - 03/2020
2	Type 2 Diabetes Mellitus (MODY) 03/2020 - 04/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2019 - 01/2019
2	Necrosis 01/2018 - 10/2016
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 06/2015
2	Infections 05/2015 - 02/2009
1	Obesity 01/2022
1	Circulating Neoplastic Cells 01/2021
1	Metabolic Diseases (Metabolic Disease) 03/2020
1	Lewis Lung Carcinoma 01/2018
1	Pain (Aches) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 05/2017
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

23	14-O-phosphonooxymethyltriptolide disodium saltIBA 09/2019 - 10/2012
23	triptolideIBA 07/2019 - 10/2012
10	DiterpenesIBA 01/2019 - 10/2012
9	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2012
9	ProdrugsIBA 01/2019 - 07/2013
8	Pharmaceutical PreparationsIBA 11/2020 - 09/2011
4	CytokinesIBA 11/2021 - 05/2015
3	Gemcitabine FDA Link 01/2022 - 07/2015
3	EnzymesIBA 01/2021 - 06/2014
3	LipidsIBA 12/2018 - 07/2003
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 05/2015
3	NF-kappa B (NF-kB)IBA 11/2017 - 04/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 03/2020
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 11/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 12/2020 - 11/2020
2	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 01/2016
2	HexosaminesIBA 01/2020 - 01/2018
2	Endoplasmic Reticulum Chaperone BiPIBA 12/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2018
2	Sp1 Transcription FactorIBA 07/2019 - 11/2013
2	O-GlcNAc transferaseIBA 01/2019 - 01/2018
2	Glutamine (L-Glutamine)FDA Link 01/2019 - 01/2018
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2018 - 01/2018
2	Arginine (L-Arginine)FDA Link 01/2018 - 11/2016
2	CeruletideIBA 01/2018 - 11/2016
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 07/2017 - 07/2013
2	RNA (Ribonucleic Acid)IBA 11/2016 - 01/2012
2	MicroRNAs (MicroRNA)IBA 11/2016 - 07/2013
2	Cathepsin BIBA 10/2016 - 01/2012
2	Death Domain ReceptorsIBA 12/2015 - 06/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015 - 06/2014
2	LigandsIBA 12/2015 - 06/2014
2	CaspasesIBA 06/2015 - 01/2013
2	Glycoproteins (Glycoprotein)IBA 05/2015 - 01/2012
2	Phosphotransferases (Kinase)IBA 06/2014 - 04/2009
2	SugarsIBA 08/2012 - 11/2010
2	Polysaccharides (Glycans)IBA 11/2010 - 02/2005
1	Nucleoside Q (Queuosine)IBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2021
1	GSK2837808AIBA 01/2021
1	Lactate Dehydrogenase 5IBA 01/2021
1	IntegrinsIBA 10/2020
1	PolyaminesIBA 10/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2019
1	Long Noncoding RNAIBA 11/2019
1	Epoxy Compounds (Epoxides)IBA 01/2019
1	CholesterolIBA 12/2018
1	CaveolinsIBA 12/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	Naltrexone (ReVia)FDA LinkGeneric 01/2018
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	GastrinsIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	AntibodiesIBA 01/2018
1	AntioxidantsIBA 01/2018
1	plerixafor FDA Link 01/2018
1	Opioid Receptors (Opioid Receptor)IBA 01/2018
1	palmitoleic acidIBA 01/2018
1	AndrogensIBA 05/2017
1	Androgen Receptors (Androgen Receptor)IBA 05/2017
1	CateninsIBA 01/2017

Therapy/Procedure

26	Therapeutics 01/2022 - 09/2013
9	Drug Therapy (Chemotherapy) 01/2022 - 07/2013
2	Immunotherapy 01/2021 - 01/2018
2	Precision Medicine 01/2018 - 09/2017
1	Analgesia 01/2018
1	Injections 01/2018
1	Castration 05/2017